Light Therapy Shows Promise in Reducing Heart Damage After Non-Cardiac Surgery

Intense light therapy may protect the heart from injury after non-cardiac surgery by activating protective proteins and improving vascular health, offering a promising new approach to reduce postoperative cardiac complications.
Recent research indicates that intense light therapy administered after non-cardiac surgical procedures can significantly protect the heart from injury. A study conducted by CU Anschutz Medical Campus found that patients receiving 30 minutes of bright light at sunrise over five days experienced an increase in the protective protein PER2 and elevated levels of ANGPTL4, both of which bolster vascular health. Concurrently, these patients exhibited lower levels of troponin, a biomarker associated with heart damage and increased mortality risk. The findings suggest that bright light enhances circadian rhythms, which in turn reinforce cardiac resilience, especially in patients over 45 who are at higher risk for myocardial injury post-surgery. In animal models, bright light exposure not only strengthened the endothelium but also activated pathways involving PER2 and ANGPTL4. Notably, the therapy's benefits were observed even when PER2 was absent, hinting at alternative protective mechanisms like ANGPTL4 administration. The research reinforces the potential of light therapy as a novel, non-invasive approach to prevent myocardial injuries, which currently lack specific treatments and are linked to about 20% of complications after surgery. Preliminary trials in humans mirror the positive results seen in animals, with the hope that further clinical studies will cement intense light therapy as a standard protective strategy in surgical care.
Stay Updated with Mia's Feed
Get the latest health & wellness insights delivered straight to your inbox.
Related Articles
Multilingual Virtual Avatar Enhances Patient Comfort During Autonomous Ultrasound Procedures
A new study shows that using a multilingual virtual avatar during autonomous ultrasound exams significantly lowers patient stress and builds trust, making procedures more humane and accessible.
Mouse Study Shows Tirzepatide Slows Growth of Obesity-Related Breast Cancer
A groundbreaking mouse study presented at ENDO 2025 shows that tirzepatide, an anti-obesity medication, can slow the growth of breast cancer linked to obesity. These findings may pave the way for new cancer treatments targeting obesity-related pathways.
Innovative AI-Powered Exoskeletons Offer New Hope for Stroke Rehabilitation
Georgia Tech researchers have developed AI-adaptive exoskeletons that help stroke survivors improve mobility by learning and adjusting to each individual's walking pattern in real time, promising a future of personalized mobility support.
Balancing Risks and Benefits in Children's Play Environments for Healthy Development
A new assessment tool developed by researchers at the University of Technology Sydney helps balance safety and developmental benefits in children's play environments, promoting healthy growth through controlled risk-taking.